The Catherine Elizabeth Blair Memorial Foundation funded two research grants this year.
NEW Collaboration: The foundation has granted $36,000 to Dr. Kelly Goldsmith and Dr. Thomas Cash of Emory University to support the ongoing Phase 1 Trial: NANT 2017-01: A Phase 1 Study of 131 I-MIBG with Dinutuximab +/- Vorinostat for Relapsed/Refractory Neuroblastoma. We are excited to be a part of this clinical trial that combines MIBG therapy with a monoclonal antibody.
The foundation continues to support Dr. Tony Sandler, Dr. Marie Nelson, and the research team for Accelerating Research Towards Neuroblastoma Treatments. This year's $25,000 grant will help the team move to the final steps prior to designing clinical trials in patients.
Comentários